At the 62nd European Renal Association Congress (ERA 2025), Everest Medicines unveiled new clinical data on EVER001 (previously known as…
Browsing: Pharma
In 2025, the policies regarding traditional Chinese medicine (TCM) in Mainland China are being continuously optimized, providing broader opportunities for…
Key Highlights Clinical trial to evaluate the safety and efficacy of YK012 in primary membranous nephropathy Globally, this is the…
– Over 1,000 investment and business matching meetings lined up underscoring Hong Kong’s role as a healthcare investment hub -…
– Building a New Blueprint for Global Dentistry Modern Dental Group Limited (Modern Dental or the Group, HKG: 3600), a leading…
– Asia Summit on Global Health and Medical and Healthcare Fair open concurrently – Global healthcare leaders gather in Hong…
TruMerit™ (formerly CGFNS International) welcomed the release this week of the World Health Organization’s State of the World’s Nursing Report,…
– Asia Summit on Global Health and Medical and Healthcare Fair run concurrently – The 5th Asia Summit on Global Health launches new Silver…
– Offer price of S$0.25 per share is at an attractive premium of 61.3% over the last traded price being…
Over 100,000 registrations received from nurses across 199* countries – a 28% increase from the third edition, which received 78,000+…
Everest Medicines (HKG: 1952) today announced that the supplemental New Drug Application (sNDA) for NEFECON has received full approval from…
A new report released today by the World Hepatitis Alliance (WHA) reveals widespread knowledge gaps, inequities in access, and critical…
With six newly established, identical BSL-2 laboratories now operational, biologics CDMO Northway Biotech can conduct VCS programs for up to…
Azurite Medical and Wellness, founded by entrepreneur Trina Eliassen, announces the launch of its innovative medical tourism service that combines…
Names Bob White Representative Executive Officer, President, Chief Executive Officer and a new Director candidate Olympus Corporation (Olympus), a global MedTech…
– Results from the first patient cohort (N=5) of an open-label proof of concept academic study with low-dose IL-2 and…
HighTide Therapeutics, Inc. (HKG: 2511), a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for chronic…
Everest Medicines (HKG: 1952, Everest, or the Company), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization…
– Continuoued to consolidate The leading position of nuclear medicine and facilitated the development of nuclear medical equipment as a…
HighTide Therapeutics Announces HTD1801 Meets the Primary Endpoints in Two Phase 3 Clinical Trials in Patients with Type 2 Diabetes…